EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 56 / No 3 (September 2024) J Extra Corpor Technol, 56 3 (2024) 120-124 References
Open Access
Issue
J Extra Corpor Technol
Volume 56, Number 3, September 2024
Page(s) 120 - 124
DOI https://doi.org/10.1051/ject/2024018
Published online 20 September 2024
  1. Horrow JC. Protamine: a review of its toxicity. Anesth Analg. 1985;4:348–361 (III). [Google Scholar]
  2. Ralley FE, FRCA. The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration. Anesth Analg. 1999;88(3):505–507. [PubMed] [Google Scholar]
  3. Levy JH, Ghadimi K, Kizhakkedathu JN, Iba T. What’s fishy about protamine? Clinical use, adverse reactions, and potential alternatives. J Thromb Haemost. 2023;21(7):1714–1723. [CrossRef] [PubMed] [Google Scholar]
  4. Levy JH, Schwieger IM, Zaidan JR, et al. Evaluation of patients at risk for protamine reactions. J Thorac Cardiovasc Surg. 1989;98(2):200–204. [CrossRef] [PubMed] [Google Scholar]
  5. Lowenstein E, Johnston WE, Lappas DG, et al. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology. 1983;59(5):470–473. [CrossRef] [PubMed] [Google Scholar]
  6. Nybo M, Madsen JS. Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol. 2008;103(2):192–196. [CrossRef] [PubMed] [Google Scholar]
  7. Suksompong S, et al. H1 and H2 antihistamines pretreatment for attenuation of protamine reactions after cardiopulmonary bypass: a randomized-controlled study. Ann Palliat Med. 2023;12(1):47–59. [CrossRef] [PubMed] [Google Scholar]
  8. Lee JZ, Boilson BA, Killu AM. Letter to the editor – Hemodynamic collapse following protamine sulfate: the impact of acute pulmonary vasoconstriction. Heart Rhythm Case Rep. 2020;6:547. [Google Scholar]
  9. Fratacci MD, Frostell CG, Chen TY, et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology. 1991;75(6):990–999. [CrossRef] [PubMed] [Google Scholar]
  10. Horrow J. Transfusion medicine and coagulation disorders. In: Kaplan JA, Reich DL, Konstadt SN, editor. Cardiac anesthesia, 4th ed. Philadelphia: WB Saunders; 1999, p. 1129–1137 (III). [Google Scholar]
  11. Morel DR, Zapol WM, Thomas SJ, Kitain EM, Robinson DR, Moss J, et al. C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin. Anesthesiology. 1987;66:597–604. [CrossRef] [PubMed] [Google Scholar]
  12. Weiler JM, Gellhaus MA, Carter JC, et al. A prospective study of the risk of an immediate adverse reaction of protamine sulphate during cardiopulmonary bypass surgery. J Allergy Clin Immunol. 1990;85:713–719. [CrossRef] [PubMed] [Google Scholar]
  13. Geurink KR, Granger CB, Liao L, et al. A reversal of fortune: a case of cardiovascular collapse following protamine sulfate infusion. Heart Rhythm Case Rep. 2020;6:322–323. [Google Scholar]
  14. Pannu BS, Sanghavi DK, Guru PK, et al. Fatal right ventricular failure and pulmonary hypertension after protamine administration during cardiac transplantation. Indian J Crit Care Med. 2016;20(3):185–187. [CrossRef] [PubMed] [Google Scholar]
  15. Zheng G, Xin S, Yong-Jian Z, et al. Use of epoprostenol to treat severe pulmonary vasoconstriction induced by protamine in cardiac surgery. Medicine (Baltimore). 2018;97(28), e10908. [CrossRef] [PubMed] [Google Scholar]
  16. Lock R, Hessel EA 2nd. Probable reversal of protamine reactions by heparin administration. J Cardiothorac Anesth. 1990;4(5):604–608. [CrossRef] [PubMed] [Google Scholar]
  17. Horrow JC. Editorial: Heparin reversal of protamine toxicity: have we come full circle? J Cardiothorac Anesth. 1990;4(5):539–542. [CrossRef] [PubMed] [Google Scholar]
  18. Ashraf SS, Tian Y, Zacharrias S, et al. Effects of cardiopulmonary bypass on neonatal and paediatric inflammatory profiles. Eur J Cardiothorac Surg. 1997;12:862–868. [CrossRef] [PubMed] [Google Scholar]
  19. Joanna M, Bartlomiej K, Piotr P, et al. Cardiovascular and respiratory toxicity of protamine sulfate in zebrafish and rodent models. Pharmaceutics. 2021;13(3):359. [CrossRef] [PubMed] [Google Scholar]
  20. Fairman RP, Sessler CN, Bierman M, et al. Protamine sulfate causes pulmonary hypertension and edema in isolated rat lungs. J Appl Physiol. 1987;62(4):1363–1367. [CrossRef] [PubMed] [Google Scholar]
  21. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease: part one. Am J Respir Crit Care Med. 1994;150:833–852. [CrossRef] [PubMed] [Google Scholar]
  22. Rajagopal S, Ruetzler K, Ghadimi K, et al., on behalf of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, and the Council on Cardiovascular and Stroke Nursing. Evaluation and management of pulmonary hypertension in noncardiac surgery: a scientific statement from the American Heart Association. Circulation. 2023;147:1317–1343. [CrossRef] [PubMed] [Google Scholar]
  23. Vaidya A, Kirkpatrick J. Right ventricular anatomy, function and echocardiographic evaluation. In: Otto C, editor. The practice of clinical echocardiography. 5th ed. Amsterdam: Elsevier Publishing; 2016. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.